Development of Biosimilars in Brazil
This article presents a brief overview of the biosimilar industry in Brazil and in the world.Biosimilars are drugs originating from therapeutic or biological proteins, whose patents are expired or are going to expire.Similarly to the generic pharmaceutical industry, the expiration of patents for biologics allows the emergence of a new segment in th